Genomic epidemiology of Staphylococcus aureus among Native American populations in Southwestern United States

NIH RePORTER · NIH · K22 · $107,914 · view on reporter.nih.gov ↗

Abstract

Staphylococcus aureus causes millions of infections in the US annually, and each year, at least 72,000 cases of severe invasive disease and 10,000 deaths are attributed to the difficult-to-treat methicillin-resistant S. aureus (MRSA). In the US, a community-associated (CA) MRSA clone, USA300, is known to be a particularly common, hypervirulent strain type that spreads easily and persists for a prolonged period in households. Historically, Native Americans and indigenous people in general have been burdened by high rates of infectious disease. There is data to suggest the rate of S. aureus invasive disease among Native Americans may be double that of the general population; however, few studies of S. aureus have been conducted among these populations and surveillance data, which are integral for control efforts, remain limited. Consequently, little is known about the burden of invasive disease, asymptomatic carriage rates, antibiotic resistance prevalence, and transmission dynamics in these communities. Identifying disparities in these rates and elucidating routes of transmission have direct implications for control efforts in clinical and community settings among indigenous people and epidemiologically similar communities abroad. Further, fundamental questions regarding S. aureus evolution and pathology remain unanswered. These include the evolution of traits responsible for persistent carriage and transition from carriage to disease as well as the relative contribution of host risk factors, pathogen genomics, and pathogen-pathogen interactions to this dynamic. In this study, we seek to determine the comparative importance of host and pathogen factors associated with disproportionate rates of disease among Native Americans by combining host risk factor analysis, pathogen whole-genome sequencing, pathogen phylodynamic analysis, and comparative genomics. To this end, we will investigate genomic epidemiology of S. aureus among Native Americans living on or around Navajo Nation or White Mountain Apache (N/WMA) tribal lands, identifying invasive disease among individuals seeking care at Indian Health Service hospitals (Aim 1), assessing carriage in the community (Aim 2), and investigating host and pathogen factors associated with carriage, disease, and transmission (Aim 3). Expanding on Aim 3, we will investigate the population structure and origins of the N/WMA SA strains using phylogenetics to determine if they are representative of prevalent US lineages, including the dominant CA-MRSA USA300. We expect that the study population will have a higher S. aureus carriage prevalence than the general US population as well as a greater proportion of strains that are methicillin resistant compared to national trends. We also anticipate that transmission is driven, in part, by population- specific, community-associated risk factors, and involves strains genetically related to USA300. Understanding the genomic epidemiology of S. aureus provides tools to contro...

Key facts

NIH application ID
9991751
Project number
5K22AI141582-02
Recipient
UNIVERSITY OF CENTRAL FLORIDA
Principal Investigator
Taj Hassan Azarian
Activity code
K22
Funding institute
NIH
Fiscal year
2020
Award amount
$107,914
Award type
5
Project period
2019-08-08 → 2021-07-31